Qualigen Therapeutics, Inc. financial data

Symbol
QLGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
2042 Corte Del Nogal, Carlsbad, California, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
RITTER PHARMACEUTICALS INC (to 5/20/2020)
Latest financial report
10-Q - Q2 2024 - Aug 14, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.7 % -71.5%
Quick Ratio 20.2 % -21%
Debt-to-equity 938 % +1361%
Return On Equity -205 % -93.2%
Return On Assets -98.5 % -32.2%
Operating Margin -196 % +49.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 9.61M shares +90.3%
Common Stock, Shares, Outstanding 9.61M shares +90.3%
Entity Public Float 4.57M USD -79.2%
Common Stock, Value, Issued 47.5K USD +10.6%
Weighted Average Number of Shares Outstanding, Basic 7.6M shares +50.5%
Weighted Average Number of Shares Outstanding, Diluted 7.6M shares +50.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 6.07M USD +26.7%
Research and Development Expense 3.87M USD +8.4%
General and Administrative Expense 4.34M USD -49%
Operating Income (Loss) -8.21M USD +30.8%
Nonoperating Income (Expense) -1.01M USD -187%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -9.22M USD +24.5%
Income Tax Expense (Benefit) -1.21K USD -130%
Net Income (Loss) Attributable to Parent -1.58M USD +54.5%
Earnings Per Share, Basic -0.21 USD/shares +69.6%
Earnings Per Share, Diluted -0.21 USD/shares +69.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 539K USD 0%
Inventory, Net 1.56M USD +19.3%
Other Assets, Current 11.6K USD
Assets, Current 534K USD -89%
Property, Plant and Equipment, Net 499K USD +51.3%
Operating Lease, Right-of-Use Asset 1.31M USD -15%
Intangible Assets, Net (Excluding Goodwill) 5.83M USD -0.43%
Goodwill 626K USD -87.2%
Other Assets, Noncurrent 866K USD +4626%
Assets 534K USD -95.9%
Accounts Payable, Current 1.85M USD +5.56%
Accrued Liabilities, Current 987K USD -50.2%
Liabilities, Current 4.81M USD -43.3%
Deferred Income Tax Liabilities, Net 150K USD
Operating Lease, Liability, Noncurrent 1.17M USD -18%
Liabilities 4.14M USD -59.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 132K USD +101%
Retained Earnings (Accumulated Deficit) -120M USD -8.78%
Stockholders' Equity Attributable to Parent -2.1M USD -129%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -4.28M USD -229%
Liabilities and Equity 534K USD -95.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -784K USD +70.3%
Net Cash Provided by (Used in) Financing Activities 475K USD
Net Cash Provided by (Used in) Investing Activities -198K USD -299%
Common Stock, Shares Authorized 225M shares 0%
Common Stock, Shares, Issued 9.61M shares +90.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -800K USD +69.2%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 119K USD -79.9%
Deferred Tax Assets, Valuation Allowance 17.8M USD -61%
Deferred Tax Assets, Gross 17.8M USD -61%
Operating Lease, Liability 1.43M USD -11.1%
Depreciation 84K USD -4.55%
Payments to Acquire Property, Plant, and Equipment 198K USD +299%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -9.7M USD +44.5%
Lessee, Operating Lease, Liability, to be Paid 1.74M USD -21%
Property, Plant and Equipment, Gross 5.25M USD +40.3%
Operating Lease, Liability, Current 257K USD +44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 391K USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 379K USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 310K USD -47.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 402K USD +3%
Deferred Tax Assets, Operating Loss Carryforwards 8.64M USD -73.5%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 379K USD -5.8%
Additional Paid in Capital 116M USD +3.14%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 5K USD +66.7%
Depreciation, Depletion and Amortization 58.7K USD +97.2%
Share-based Payment Arrangement, Expense 33.1K USD -63.9%
Interest Expense 68K USD